During the past decade, University of Wisconsin-Madison, Dept of Ophthalmology/Retina Service conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 5 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Wisconsin-Madison, Dept of Ophthalmology/Retina Service" #1 collaborator was "National Eye Institute (NEI)" with 10 trials as a collaborator, "Allergan" with 4 trials as a collaborator, "Genentech, Inc." with 4 trials as a collaborator, "Regeneron Pharmaceuticals" with 3 trials as a collaborator and "National Institutes of Health (NIH)" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "University of Wisconsin-Madison, Dept of Ophthalmology/Retina Service" are "Diabetic Macular Edema" (10 trials), "Diabetic Retinopathy" (6 trials), "Choroidal Melanoma" (2 trials), "Diabetes" (1 trials) and "Indeterminate Lesions" (1 trials). Many other conditions were trialed in "University of Wisconsin-Madison, Dept of Ophthalmology/Retina Service" in a lesser frequency.

Most popular intervention types in "University of Wisconsin-Madison, Dept of Ophthalmology/Retina Service" are "Drug" (10 trials), "Procedure" (8 trials), "Behavioral" (2 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "AU-011" (2 trials), "Deferred aflibercept" (2 trials), "Deferred laser" (2 trials), "Prompt aflibercept" (2 trials) and "Sham injection" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of Wisconsin-Madison, Dept of Ophthalmology/Retina Service" are 15 trials for "All" genders.

Currently, there are NaN active trials in "University of Wisconsin-Madison, Dept of Ophthalmology/Retina Service". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in University of Wisconsin-Madison, Dept of Ophthalmology/Retina Service, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of Wisconsin-Madison, Dept of Ophthalmology/Retina Service, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".